Screener
Dyne Therapeutics, Inc. DYN Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | (32,847) | 4,999 |
| Other non-current assets | 28 | — |
| Accounts payable and other liabilities | (4,804) | (8,601) |
| Net cash used in operating activities | (144,922) | (105,893) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (221) | (981) |
| Purchases of marketable securities | (64,278) | (65,970) |
| Maturities of marketable securities | 33,459 | 65,439 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s operating cash flow?
- Dyne Therapeutics, Inc. (DYN) reported operating cash flow of -$144.92M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s operating cash flow changed year-over-year?
- Dyne Therapeutics, Inc.'s operating cash flow decreased by 36.9% year-over-year, from -$105.89M to -$144.92M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s operating cash flow has grown at a 35.5% compound annual growth rate (CAGR), from -$119.56M to -$403.21M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Dyne Therapeutics, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude